Pharmacological heterogeneity limits antidepressant study
- PMID: 12896954
- PMCID: PMC1126675
- DOI: 10.1136/bmj.327.7409.289-a
Pharmacological heterogeneity limits antidepressant study
Comment on
-
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.BMJ. 2003 May 10;326(7397):1014. doi: 10.1136/bmj.326.7397.1014. BMJ. 2003. PMID: 12742924 Free PMC article.
References
-
- MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 2003;326: 1014. (10 May.) - PMC - PubMed
-
- Katona CL, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DR, Lock T, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166: 80-6. - PubMed
-
- Hale AS. The treatment of depression: the reuptake inhibitors. In: Honig A, van Praag HM, eds. Depression: neurobiological, psychopathological and therapeutic advances. Chichester: Wiley, 1997.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical